Can-Fite BioPharma (CANF) Assets (QoQ) (2014 - 2023)
Can-Fite BioPharma (CANF) Assets (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Can-Fite BioPharma | 2.77 Mn | -8.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8.94% |
| Sep 30, 2023 | -16.89% |
| Jun 30, 2023 | -18.21% |
| Mar 31, 2023 | 45.31% |
| Dec 31, 2022 | -26.94% |
| Sep 30, 2022 | -13.83% |
| Jun 30, 2022 | -17.38% |
| Mar 31, 2022 | -11.88% |
| Dec 31, 2021 | 38.35% |
| Sep 30, 2021 | 51.23% |
| Jun 30, 2021 | -24.03% |
| Mar 31, 2021 | 33.80% |
| Dec 31, 2020 | -28.54% |
| Sep 30, 2020 | 4.11% |
| Dec 31, 2019 | -30.44% |
| Sep 30, 2019 | -14.02% |
| Jun 30, 2019 | 82.49% |
| Mar 31, 2019 | -5.82% |
| Dec 31, 2018 | -26.54% |
| Sep 30, 2018 | -1.45% |